Skip to content

Organon logo

Main menu
      • Our focus
      • Products list
      • Patient support programs
      • Organon Pro for healthcare professionals
      • Safety data sheets
      • Product patents
      • Leadership team
      • Board of Directors
      • Corporate governance
    • Business development
    • Our culture
    • Our stories
    • Policies & positions
    • Environmental, social & governance
      • Our Suppliers
      • Supplier relationship management
    • Media
    • News
    • Investor relations overview
    • Events & presentations
    • SEC filings
    • Financial Information
    • Investor resources
  • Careers

Contact us

Visit Organon's Twitter Opens a new window Visit Organon's Facebook Opens a new window Visit Organon's LinkedIn Opens a new window Visit Organon's Instagram Opens a new window Visit Organon's YouTube Opens a new window

Main menu

Organon site directory

  • Organon

    • Brazil
    • Canada  English  ·  French
    • Latin America
    • Mexico
    • USA
  • Organon

    • Austria
    • Belgium  Dutch  ·  English  ·  French
    • Bulgaria
    • Czech Republic
    • Denmark
    • Estonia
    • Finland
    • France
    • Germany
    • Hungary
    • Ireland
    • Italy
    • Latvia
    • Lithuania
    • Luxembourg  English  ·  French
    • Netherlands  Dutch  ·  English
    • Norway
    • Poland
    • Portugal
    • Romania
    • Russia
    • Serbia
    • Slovakia
    • Slovenia
    • Spain
    • Sweden
    • Switzerland  French  ·  German  ·  English
    • Ukraine  Ukrainian  · 
    • United Kingdom
  • Organon

    • Australia
    • Hong Kong, China
    • Indonesia
    • Japan
    • Malaysia
    • New Zealand
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Organon

    • Egypt
    • Israel
    • Jordan
    • KSA
    • Kuwait
    • Lebanon
    • Northwest Africa  French  ·  Arabic  ·  Turkey
    • Oman
    • South Africa
    • Turkey
    • UAE
View all locations and contact information

What can we help you find?

Search for:
Her story

A Mother Navigates Her Son’s Childhood Eczema

Organon Global Communications team member Lauren Gencarelli shares her son’s experience living with eczema

March 5, 2025

Share this article

Angry Skin: Early Signs of Chronic Skin Condition

When Lauren’s son Tyler was born, she expected him to have the quintessential baby-smooth skin we always hear about, and never imagined childhood eczema. But within the first month, Lauren noticed that his skin was dry, and she began to see rough, red patches. After trying nearly every over-the-counter lotion she could find, Lauren felt she was fighting a losing battle.

With Tyler still suffering, Lauren couldn’t help but think that she was doing something wrong as a mother. Her son’s red cheeks brought on uninvited comments from others that he was either too hot or too cold, adding to her anxiety and self-doubt. Friends and family tried their best to offer support, but they struggled to give Lauren advice on something they hadn’t experienced.

As a toddler, Tyler’s skin worsened. A long list of triggers, such as seasonal changes, fragrances, and stress, caused his skin to react, leading to what the family began to call his “angry skin.” As a result, Lauren had to be mindful of everything that came in contact with Tyler’s skin. She found herself feeling envious of parents who could bathe and moisturize their kids without those worries.

Chasing Relief: Managing Childhood Eczema Prone Skin

Fortunately, Lauren had a supportive pediatrician who diagnosed Tyler with eczema when he was still an infant. Also known as atopic dermatitis, eczema is a chronic inflammatory skin condition characterized by itchy and swollen skin that affects approximately 16.5 million adults and about 10% of all children.1,2,3  The diagnosis, though, was just the beginning of what would soon to be a difficult journey to find appropriate treatment options to address Tyler’s eczema.

Family photo of toddler boy with eczema, Mom, infant girl and Dad

Initially, Lauren worked with her pediatrician to develop an eczema skincare routine using over-the-counter lotions. But as Tyler got older and his eczema worsened, the family’s go-to treatments no longer cut it. They turned to her son’s pediatrician for prescription suggestions, but they struggled to find options that addressed the more difficult-to-treat areas where Tyler’s eczema was particularly severe. Eventually, Lauren turned back to over-the-counter lotions for a gentler approach.

Playing Offense: Living with Eczema

As part of Organon’s Global Communications team, Lauren is driven by her personal experience as a mother. Her commitment to the company’s vision to help make a better and healthier every day a reality for patients, families, and communities is deeply influenced by her son’s ordeal. His journey has fueled her advocacy for patients with similar unmet needs, and she draws from her own story to bring a more personal, heartfelt approach to her work.

Mom hugging child in baseball uniform

Now 10 years old, Tyler has largely outgrown the worst of his eczema. While occasional flare-ups still occur, Lauren feels better equipped to manage them. She’s found a balance between staying ahead of his childhood eczema triggers, like his sports gear, and allowing Tyler to live his life with few limitations. Tyler still plays all the sports he loves and doesn’t let his “angry skin” stop him from thriving.

For Lauren, this journey has been one of constant adaptation—learning and growing alongside her son. She’s not just advocating for her child; she’s become an advocate for others facing similar challenges. Through it all, Lauren’s unwavering support and dedication have made all the difference in Tyler’s ability to embrace life’s joys despite his childhood eczema.


1. Rea CJ, Tran KD, Jorina M, Wenren LM, Hawryluk EB, Toomey SL. A Randomized Controlled Trial of an Eczema Care Plan. Acad Pediatr. 2018 Sep-Oct;18(7):789-796. doi: 10.1016/j.acap.2018.02.015. Epub 2018 Mar 2. PMID: 29505898.

2. Shaw TE, Currie GP, Koudelka CW, Simpson EL. Eczema prevalence in the United States: data from the 2003 National Survey of Children’s Health. J Invest Dermatol. 2011;131(1):67-73. doi:10.1038/jid.2010.251

3. Chiesa Fuxench ZC, Block JK, Boguniewicz M, et al. Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult Population. J Invest Dermatol. 2019;139(3):583-590. doi:10.1016/j.jid.2018.08.028

Connect with us on social

Linkedin icon Opens a new window Twitter icon Opens a new window Facebook icon Opens a new window Instagram icon Opens a new window YouTube icon Opens a new window
Organon logo

Company

  • About us
  • Our Leaders
  • Environmental, social & governance
  • Policies & positions

Resources

  • Patient resources
  • Investor relations
  • Media
  • Organon Pro for healthcare professionals

Contact us

  • Contact information
  • Global locations
  • Forward-Looking Statement
  • Cookie policy
  • Privacy Policy
  • Consumer Health Data Policy
  • Terms of Use
  • Sitemap
© 2025 Organon group of companies. All rights reserved. ORGANON and the ORGANON Logo are trademarks of the Organon group of companies. This site is intended for residents of the United States.
Level Access website accessibility icon. Opens a new window TRUSTe Opens a new window

You are leaving Organon.com

Cancel Continue Opens a new window

Forward-looking statement of Organon

Any statements set forth on this website that are not historical facts are considered “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of Organon’s management and are subject to significant risks and uncertainties. By their nature, forward-looking statements involve risks and uncertainties because they depend on circumstances that may or may not occur in the future. Although these statements are based on assumptions that we believe are reasonable when made, we caution you that forward-looking statements are not guarantees of future performance and you should not place undue reliance on them.

Organon undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s other filings with the Securities and Exchange Commission (SEC), including its registration statement on Form 10, available at the SEC’s Internet site (www.sec.gov Opens a new window).

Decline Accept